Charles Schwab’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-14,827
| Closed | -$253K | – | 3198 |
|
|
2019
Q2 | $253K | Sell |
14,827
-8,468
| -36% | -$144K | ﹤0.01% | 3055 |
|
|
2019
Q1 | $786K | Buy |
23,295
+40
| +0.2% | +$1.35K | ﹤0.01% | 2623 |
|
|
2018
Q4 | $680K | Buy |
23,255
+1,651
| +8% | +$48.3K | ﹤0.01% | 2657 |
|
|
2018
Q3 | $1.33M | Sell |
21,604
-1,666
| -7% | -$103K | ﹤0.01% | 2533 |
|
|
2018
Q2 | $1.72M | Buy |
23,270
+10,418
| +81% | +$769K | ﹤0.01% | 2420 |
|
|
2018
Q1 | $844K | Buy |
12,852
+2,233
| +21% | +$147K | ﹤0.01% | 2572 |
|
|
2017
Q4 | $894K | Sell |
10,619
-2,503
| -19% | -$211K | ﹤0.01% | 2542 |
|
|
2017
Q3 | $1.52M | Buy |
13,122
+4,200
| +47% | +$485K | ﹤0.01% | 2376 |
|
|
2017
Q2 | $1.04M | Buy |
8,922
+1,555
| +21% | +$182K | ﹤0.01% | 2439 |
|
|
2017
Q1 | $910K | Buy |
7,367
+411
| +6% | +$50.8K | ﹤0.01% | 2450 |
|
|
2016
Q4 | $948K | Buy |
6,956
+369
| +6% | +$50.3K | ﹤0.01% | 2447 |
|
|
2016
Q3 | $1.31M | Buy |
6,587
+2,277
| +53% | +$453K | ﹤0.01% | 2317 |
|
|
2016
Q2 | $559K | Buy |
4,310
+1,894
| +78% | +$246K | ﹤0.01% | 2552 |
|
|
2016
Q1 | $226K | Buy |
2,416
+41
| +2% | +$3.84K | ﹤0.01% | 2859 |
|
|
2015
Q4 | $482K | Buy |
2,375
+52
| +2% | +$10.6K | ﹤0.01% | 2657 |
|
|
2015
Q3 | $338K | Buy |
2,323
+133
| +6% | +$19.4K | ﹤0.01% | 2778 |
|
|
2015
Q2 | $466K | Buy |
+2,190
| New | +$466K | ﹤0.01% | 2693 |
|